Your browser doesn't support javascript.
loading
Prospective minimal residual disease monitoring to predict relapse of acute promyelocytic leukemia and to direct pre-emptive arsenic trioxide therapy.
Grimwade, David; Jovanovic, Jelena V; Hills, Robert K; Nugent, Elizabeth A; Patel, Yashma; Flora, Rajinder; Diverio, Daniela; Jones, Katy; Aslett, Hannah; Batson, Elaine; Rennie, Kristian; Angell, Roger; Clark, Richard E; Solomon, Ellen; Lo-Coco, Francesco; Wheatley, Keith; Burnett, Alan K.
Afiliação
  • Grimwade D; Dept of Medical and Molecular Genetics, King's College London School of Medicine, 8th Floor, Tower Wing, Guy's Hospital, London SE1 9RT, United Kingdom. david.grimwade@genetics.kcl.ac.uk
J Clin Oncol ; 27(22): 3650-8, 2009 Aug 01.
Article em En | MEDLINE | ID: mdl-19506161

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Óxidos / Arsenicais / Leucemia Promielocítica Aguda / Neoplasia Residual / Recidiva Local de Neoplasia Tipo de estudo: Etiology_studies / Guideline / Incidence_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Idioma: En Ano de publicação: 2009 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Óxidos / Arsenicais / Leucemia Promielocítica Aguda / Neoplasia Residual / Recidiva Local de Neoplasia Tipo de estudo: Etiology_studies / Guideline / Incidence_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Idioma: En Ano de publicação: 2009 Tipo de documento: Article